Blood & Cancer

Blood & Cancer

www.mdedge.com/hematology-oncology
Hematology/Oncology from MDedge


Patient-reported outcomes in cancer
Jun 13 • 30 min
Episode 21
Ask about constipation, calling patients in the middle of the night
Jun 6 • 35 min
Pearls for oncologists and hematologists
BONUS: Get to know Ilana Yurkiewicz, MD
Jun 4 • 36 min
Writer, Producer, and host of Clnical Correlation opens up about her career and her passion
Cancer-related fatigue
May 30 • 33 min
Episode 18
Hazard ratio? P value?
May 23 • 27 min
What statistics mean in practice for oncologists, hematologists, and healthcare professionals
Lung cancer: PD, PDL-1, and immunotherapy
May 16 • 35 min
Clinical pearls and insight on patients with lung cancer
ITP: When and how, pregnant patients
May 9 • 31 min
Causes and treatments of Idiopathic thrombocytopenic purpura from a Harvard Professor and Mass General Hematologist
CAR T-cell therapy: Development to access
May 2 • 32 min
Clinical pearls, insights, and perspective in hematology and oncology care
ASCO GI 2019
Apr 25 • 21 min
New data for the clinical oncologist from ASCO 2019
Drug development stats and research
Apr 18 • 26 min
Oncology and hematology news for clinical healthcare professionals.
Anemia in cancer
Apr 11 • 27 min
The official podcast of MDedge Hematology/Oncology
Breast Cancer, CDK4/6 Inhibitors
Apr 4 • 30 min
You can contact Blood & Cancer at [email protected] and you can follow us on Twitter at @mdedgeHemOnc. Richard Finn, MD, of the Geffen School of Medicine at UCLA joins guest host Jame Abraham, MD, of the Cleveland Clinic to talk about CDK4/6 inhibitors…
Sickle Cell Treatment, Part II
Mar 28 • 18 min
Episode 09: Part II of a conversation with guest host, Ify Osunkwo, MD, on sickle cell treatment. Ilana Yurkiewicz explores patients hoping for the best but expecting the worst.
Sickle Cell Treatment, Part I:
Mar 21 • 25 min
Contact us: [email protected] Twitter: @MDedgeHemOnc In this episode, John J. Strouse, MD, PhD, and Julie Kanter, MD, join guest host Ify Osunkwo, MD, of Irvine Cancer Institute/Atrium Health in Charlotte, N.C., to discuss current therapies for sickle…
Lymphoma in patients w/ HIV
Mar 14 • 24 min
Stefan K. Barta, MD, of the University of Pennsylvania, joins David Henry, MD, to discuss the treatment and diagnosis of lymphoma in patients with HIV. In Clinical Correlation, Ilana Yurkiewicz, MD, has Part 2 of her discussion on informed consent in…
Anticoagulation in cancer
Mar 7 • 30 min
Thursday, March 7, 2019
KATHERINE trial and breast cancer
Feb 28 • 25 min
Charles E. Geyer, MD, of Virginia Commonweath University joins guest host Jame Abraham, MD, of the Cleveland Clinic to discuss the KATHERINE trial and its impact on the treatment of HER2-positive breast cancer. And Ilana Yurkiewicz, MD, talks about…
How to read and review scientific papers
Feb 21 • 20 min
Concact us: [email protected] In this episode, Danial G. Haller, MD, of the University of Pennsylvania joins David H. Henry, MD, to talk about the best ways to read and review scientific literature. And Ilana Rachel Yurkiewicz, MD, talks about chaos and…
ESMO 2018 and more
Feb 14 • 23 min
Concact us: [email protected] (Please let us know what you think about transcripts or written versions of Dr. Henry’s conversations). In this episode, David Henry, MD, welcomes Daniel G. Haller, MD, to rehash research from ESMO 2018 as well as the way…
Biosimilars: Gary Lyman
Feb 7 • 29 min
Contact us: [email protected] MDedge Hematology/Oncology Twitter: @MDedgeHemOnc Ilana Yurkiewicz Twitter: @ilanayurkiewicz In this episode, Gary H. Lyman, MD joins David Henry, MD, to talk about biosimilars. Dr. Lyman talks about the definition of…
Antiemetics: Richard Gralla
Jan 31 • 27 min
In the first episode of Blood & Cancer, David Henry, MD (http://bit.ly/2MFDfzm), welcomes Richard J. Gralla, MD (http://bit.ly/2ShsxEv), or the Albert Einstein College of Medicine in New York. The topic today centers around antiemetics and ways to use…
The JCSO Interview: Dr. Maura Sammon
Aug 7, 2018 • 17 min
When cancer patients present to the emergency department with symptoms and say they’re being treated for cancer, it’s crucial for the attending physician to ascertain at the outset if the treatment is with chemotherapy or immunotherapy so that the…
David Henry’s JCSO podcast, May - June 2018
Aug 3, 2018 • 14 min
In his bimonthly podcast, Dr Henry, the JCSO Editor-in-Chief, discusses a round-up by JCSO Editor Dr Howard Burris of the top takeaways from this year’s annual ASCO meeting, as well as a series of articles focusing on CAR T-cell therapies. He also…
David Henry’s JCSO podcast, March - April 2018
Aug 1, 2018 • 12 min
In his bimonthly podcast, Dr Henry, the JCSO Editor-in-Chief, discusses a round-up by JCSO Editor Dr Howard Burris of the top takeaways from this year’s annual ASCO meeting, as well as a series of articles focusing on CAR T-cell therapies. He also…
JCSO Interview with Dr Daniel Haller
Mar 29, 2018 • 26 min
In this interview, Dr David Henry, the Editor-in-Chief of The Journal of Community and Supportive Oncology, and Dr Daniel Haller of the Abramson Cancer Center, University of Pennsylvania Perelman School of Medicine in Philadelphia, discuss recent…
JCSO Interview with Dr. Kenneth Anderson
Mar 27, 2018 • 31 min
In this interview, Dr David Henry, the Editor-in-Chief of The Journal of Community and Supportive Oncology, and Dr Ken Anderson, the Kraft Family Professor of Medicine at Harvard Medical School and an international thought leader and investigator in…
JSCO Podcast January - February 2018
Mar 23, 2018 • 15 min
In this podcast, Dr Henry highlights research articles on analgesic management in radiation oncology for painful bone metastases, hospitalizations for fracture in patients with metastatic disease, measurement of physical activity and sedentary…